Pyxis Oncology, Inc. (PYXS) Operating income 2020–2025
Pyxis Oncology, Inc. (PYXS) annual operating income history from SEC filings — each fiscal year as reported.
-$84.4MFY2025 · since FY2020: -$12.9M → -$84.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.4M | +5.6% |
| FY2024 | -$89.5M | -8.8% |
| FY2023 | -$82.2M | +33.4% |
| FY2022 | -$123.5M | -77.1% |
| FY2021 | -$69.7M | -440.7% |
| FY2020 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice